Abstract #: 620 Title: Preclinical characterization of ALG-093940, a potent and orally bioavailable small molecule PD-1/PD-L1 inhibitor for the treatment of chronic hepatitis B infection and liver ...

Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced ...

Dr. Dustin G. Shaw (Medicine): An 86-year-old woman presented to the emergency department of this hospital because of anorexia, weight loss, and weakness. The patient had been in her usual state of ...

KOLKATA: Union Home Minister Amit Shah on December 31, 2025, set an ambitious target for the West Bengal BJP unit, asking it to win at least 20 out of 28 Assembly seats under four Lok Sabha ...

In what is believed to be the first randomized placebo-controlled trial of its kind, patients with a chronic total blockage of a coronary artery who received a nonsurgical procedure to reopen the ...

Share on Pinterest Could the time of day people exercise affect their risk of obesity or diabetes? Design by MNT; Photography by lzf/Getty Images Previous studies show that having poor cardiometabolic ...

The MRCP(UK) Part 1 is the first of three components required to achieve MRCP(UK), the Membership of the Royal Colleges of Physicians of the United Kingdom. Awarded by each of the three Royal colleges ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

HCA Brandon Hospital (USF Morsani College of Medicine), Brandon, FL, USA. Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest malignancies, ranking as the fourth leading cause of ...

The BMA UK resident doctors committee welcomed the Federation of Royal College of Physicians to independently review the MRCP(UK) part 2 exam error earlier this year ...

Please provide your email address to receive an email when new articles are posted on . Duvakitug achieved greater endoscopic response rates than placebo in moderate to severe Crohn’s disease.